Insilico Medicine

Alex Zhavoronkov, CEO and co-founder
Alex Zhavoronkov, CEO and co-founder
Hong Kong | Funding: $401.3M (+)

Website: http://insilicomedicine.com/

Artificial Intelligence for Drug Discovery and Aging Research.